Sign in

You're signed outSign in or to get full access.

Susan Lee

Director at Crescent Capital BDC
Board

About Susan Lee

Susan Y. Lee (born 1980) is an Independent Director of Crescent Capital BDC, Inc. (CCAP), serving as a Class II director since 2022 with a term expiring in 2026 . She is a multi-asset allocator with experience across public equities, private equity, venture capital, real assets, credit, fixed income, and hedge fund strategies; she holds an MBA from Harvard Business School (honors; Toigo Fellow) and a BA from Stanford University (Phi Beta Kappa) . Ms. Lee also serves on the boards of CPCI and CCS IX BDC within CCAP’s fund complex and has held an other directorship at American Battery Technology Company .

Past Roles

OrganizationRoleTenureCommittees/Impact
The Broad FoundationsManaged investment assetsNot disclosed Institutional portfolio oversight
Angeles Investment AdvisorsPartnerNot disclosed Institutional advisory/investing
Black Canyon CapitalPrivate equity investorNot disclosed PE investing
Vintage Capital PartnersPrivate equity investorNot disclosed PE investing
Bain & CompanyStrategyNot disclosed Strategic advisory
The Walt Disney CompanyStrategyNot disclosed Corporate strategy

External Roles

OrganizationRoleSector/TypeNotes
Clif Family FoundationChief Investment OfficerEndowed foundationCurrent CIO
Rocketbox, LLCOwnerPrivate investment firmFamily office/private investing
White Road Capital ManagementPartnerFamily officeInvestment leadership
Sentinel Management, LLCChief Investment OfficerSingle family officeInvestment leadership
CPCIDirectorBDC (Fund Complex)CCAP-related fund complex
CCS IX BDCDirectorBDC (Fund Complex)CCAP-related fund complex
American Battery Technology CompanyDirector (past five years)Public companyOther directorship

Board Governance

  • Independence: Ms. Lee is an Independent Director (not an “interested person”) and meets audit committee independence requirements under Rule 10A-3 .
  • Board/Committee activity and attendance: In FY2024, the Board held 5 meetings; Audit 4; Nominating 2; Compensation 1. All Directors (including Ms. Lee) attended at least 75% of the aggregate meetings of the Board and committees on which they served .
  • Committee memberships and chairs:
    • Audit Committee: Member; Chair—George G. Strong Jr.; all members independent .
    • Compensation Committee: Member; Chair—Steven F. Strandberg .
    • Nominating & Corporate Governance Committee: Member; Chair—Michael S. Segal .
CommitteeMs. Lee RoleChairFY2024 MeetingsIndependence Confirmation
AuditMember George G. Strong Jr. 4 Rule 10A-3 compliant
CompensationMember Steven F. Strandberg 1 All committee members independent
NominatingMember Michael S. Segal 2 All committee members independent

Fixed Compensation

Independent Directors are compensated via cash retainers and meeting fees; chairs receive additional fees. Ms. Lee is not a committee chair and thus does not receive chair fees .

Component ($)FY2023FY2024
Annual retainer$95,000 $105,000
Regular Board meeting fee (per meeting)$2,500 $2,500
Special Board meeting fee (per meeting)$1,000 $1,000
Committee meeting fee (per meeting)$1,000 $1,000
Audit Committee Chair fee (annual)$10,000 to Aug 3, 2023; $12,500 thereafter (not applicable to Lee) $12,500 (not applicable to Lee)
Compensation Committee Chair fee (annual)$5,000 (not applicable to Lee) $5,000 (not applicable to Lee)
Nominating Committee Chair fee (annual)$5,000 (not applicable to Lee) $5,000 (not applicable to Lee)
Aggregate compensation from CCAP$117,120 $119,620
Aggregate compensation from Fund Complex$168,335 $192,740

Performance Compensation

Independent Directors receive no equity awards or performance-linked pay; compensation is cash-based (retainers and meeting fees). No performance metrics, bonus, stock awards, or options are disclosed for Directors .

Performance ElementFY2023FY2024
Equity grants (RSUs/PSUs)None disclosed None disclosed
Option awardsNone disclosed None disclosed
Bonuses/variable payNone disclosed None disclosed
Compensation performance metricsNot disclosed Not disclosed

Other Directorships & Interlocks

OrganizationRoleTypeInterlock/Conflict Consideration
CPCIDirectorBDC (Fund Complex)Co-investment governed by SEC exemptive relief requiring “required majority” of Independent Directors to approve; fair and equitable allocations per policy
CCS IX BDCDirectorBDC (Fund Complex)Same co-investment controls and allocation framework
American Battery Technology CompanyDirector (past five years)Public companyOther directorship; no CCAP-specific related party exposure disclosed

Expertise & Qualifications

  • Multi-asset class allocator with institutional advisory experience across public and private markets; roles span CIO positions and investment leadership in foundations and family offices .
  • Education: MBA Harvard Business School (honors; Toigo Fellow), BA Stanford University (Phi Beta Kappa) .
  • Audit committee financial expert designation is held by George G. Strong Jr., not Ms. Lee .

Equity Ownership

MetricAs of Record Date (Mar 19, 2025)
Shares owned (beneficial)0
Ownership %
Dollar range of CCAP sharesNone
Hedging/pledging policyHedging and pledging of CCAP securities prohibited by Insider Trading Policy
Pledged sharesNone disclosed; pledging prohibited

Governance Assessment

  • Strengths: Independent status; service across all key committees; audit committee independence compliance; consistent attendance (≥75% of aggregate meetings); robust codes prohibiting hedging/pledging and outlining personal trading restrictions; formal co-investment oversight requiring a “required majority” of Independent Directors .
  • Compensation structure: Cash-only director compensation with no equity awards or performance pay; annual retainer rose from $95,000 (2023) to $105,000 (2024) while meeting fees remained constant .
  • Alignment considerations: Ms. Lee reported zero CCAP share ownership and “None” dollar range, which may signal limited direct stock alignment; however, insider policies prohibit pledging/hedging and the fund complex structure emphasizes independent committee oversight for co-investments .
  • Conflict controls: Overlapping directorships within the fund complex (CPCI, CCS IX BDC) are subject to SEC exemptive relief and allocation policies intended to ensure fairness and protect CCAP stockholders; a “required majority” of Independent Directors must affirm fairness and non-overreaching for co-investments .